Welcome to the 3rd Gene Therapy Patient Engagement Summit
The role of patient engagement in gene therapy development is changing.
As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy is evolving.
At this interface lies the 3rd Gene Therapy Patient Engagement Summit, uniting patient advocacy and engagement experts from leading gene therapy and gene editing drug developers, along with patient groups and patients themselves. Talks, workshops, and group discussions will shed a light on how to better integrate the patient voice into gene therapy programs at crucial stages of the drug development process.
Join us in Boston this summer to gain the actionable insights, tools, and strategies you need to better implement patient input into patient-centric gene therapy programs.
Download the full event guide to see the expert speaking faculty and content in-store for 2023, carefully co-designed with leading patient-facing figures in the field.
2022 Gene Therapy Patient Engagement Attendee
Please Note, The Venue For This Event Has Been Changed
World-Class Speaker Faculty Includes:
Senior Outreach Manager
American Society of Cell & Gene Therapy
Global Head Patient Engagement
Chief Executive Officer
Irish Haemophilia Society
Senior Director - Global Patient Advocacy
Patient Advocacy & Engagement
Head of Government Affairs and Patient Advocacy, EMEA